Page last updated: 2024-10-31

metyrapone and Low Bone Density

metyrapone has been researched along with Low Bone Density in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takeshita, N1
Yoshino, T1
Mutoh, S1

Other Studies

1 other study available for metyrapone and Low Bone Density

ArticleYear
Possible involvement of corticosterone in bone loss of genetically diabetic db/db mice.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2000, Volume: 32, Issue:4

    Topics: Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Calcium; Corticosterone; Diabetes Mell

2000